Andrew Robbins

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

COGT

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Cogent Biosciences, Inc. (COGT)	Chief Executive Officer	$724,554	$21,600	$12,993,250	$13,447,680	$561,600	$14,000	$27,762,684
2024	Cogent Biosciences, Inc. (COGT)	Chief Executive Officer	$692,000	—	—	$3,734,610	$477,480	$13,800	$4,917,890
2023	Cogent Biosciences, Inc. (COGT)	Chief Executive Officer	$656,098	$393,659	$1,873,200	$4,962,615	—	$13,200	$7,898,772
2022	Cogent Biosciences, Inc. (COGT)	Chief Executive Officer	$624,283	$344,920	—	$3,409,773	—	$12,200	$4,391,176
2021	Cogent Biosciences, Inc. (COGT)	Chief Executive Officer	$592,648	$357,075	—	$1,901,555	—	$11,600	$2,862,878
2020	Cogent Biosciences, Inc. (COGT)	Chief Executive Officer	$101,731	$65,219	—	$17,692,794	—	—	$17,859,744

No earnings-call appearances or filed executive changes recorded yet.